With regulatory agencies’ broadening scope of compliance requirements along with increased frequency of inspections and upward trend in warning letters, business expediency requires management to train their personnel in ever-changing regulations. Poor compliance management, internal controls to secure data and quality systems are some of the biggest concerns.
Companies will need to realign their quality and compliance structure to conform to the constantly evolving regulatory guidelines. Any violation of regulatory methods or non-compliance of standards could increase the exposure to a company’s risk of receiving warning letters thereby reducing the company’s worth in the eyes of patients as well as investors. Consequently, it is critical that companies start making regulatory compliance a part of their corporate strategy. Such a strategy should include making compliance a proactive activity wherein stringent internal controls are established to demonstrate their commitment towards quality and compliance.
Markets and Markets, a worldwide leader in conducting currently trending seminars for the pharmaceutical industry has teamed up with industry experts for this interactive seminar titled “Proactive & Sustainable Compliance Workshop” Set for 7th & 8th December in Mumbai, it is designed by a panel of international experts to shed light on recent compliance challenges confronting the biopharmaceutical industry worldwide with a special focus on the Indian industry. This highly interactive workshop series is being offered to familiarize biopharmaceutical industry professionals withend to end compliance solutions. It will provide attendees a better understanding of compliance related elements across the biopharmaceutical supply chain.
Attending this workshop will provide you the required skills to keep your company compliance ready. It is designed for novices and advanced users alike and benefits those in senior management and manufacturing personnel from pharma, bio-pharma and life sciences industry in general.